The GT Tel Aviv team of attorneys is pleased to have received top recognition by the Legally Israel 100 league table. Our team is ranked across 10 areas, in addition
Continue Reading GT Tel Aviv Ranked in 10 Areas by Legally Israel 100 League Table
Congratulations to longstanding GT Client Enlivex on Completing Multi-Million Dollar Offering
Congratulations to our longstanding client, Enlivex Therapeutics Ltd. (“Enlivex”, NASDAQ: ENLV), which recently announced the successful completion of a $51.3 million offering of its Ordinary Shares. Leading the transaction on
Continue Reading Congratulations to longstanding GT Client Enlivex on Completing Multi-Million Dollar Offering
Over US $8 Billion Raised by Israeli Companies in 2020 on Public Markets
Israeli business Journal Globes recently reported 2020 to be a record-breaking year for Israeli companies raising capital on the New York and Tel Aviv Stock Exchanges.
Since the beginning of
Continue Reading Over US $8 Billion Raised by Israeli Companies in 2020 on Public Markets
Tel Aviv Client’s Autonomous Medical Coding Technology to be Deployed by Geisinger Hospitals
GT Tel Aviv client Nym Health (“Nym”) recently announced that Geisinger is deploying the company’s autonomous medical coding technology to all nine of its hospital emergency departments. Nym, a pioneer
Continue Reading Tel Aviv Client’s Autonomous Medical Coding Technology to be Deployed by Geisinger Hospitals
Bob Grossman to Moderate JNF’s Virtual Event on US-Israeli Innovations in the Life Sciences
As part of their free Lunch & Learn speaker series, Jewish National Fund-USA (JNF-USA) will be hosting a discussion about innovation in the realms of biotechnology, pharmaceuticals, and agricultural technology
Continue Reading Bob Grossman to Moderate JNF’s Virtual Event on US-Israeli Innovations in the Life Sciences
Federal Court Denies Request of Foreign Companies to Conduct Discovery in the United States in Aid of a Foreign-Seated Arbitration
U.S. life sciences companies with ties overseas can be encouraged by a recent federal ruling that denied the request of foreign companies to conduct discovery in the United States in
Continue Reading Federal Court Denies Request of Foreign Companies to Conduct Discovery in the United States in Aid of a Foreign-Seated Arbitration
Greenberg Traurig Represents Wells Fargo Strategic Capital in Its investment in Israeli Company EarlySense
In a matter led by Shareholder Joey Shabot and Associate Aaron Katz, Greenberg Traurig recently represented Wells Fargo Strategic Capital – the venture capital arm of Wells Fargo &
Continue Reading Greenberg Traurig Represents Wells Fargo Strategic Capital in Its investment in Israeli Company EarlySense
5 Tips to Protect Your Medtech Startup’s Innovations
David J. Dykeman authored an article titled “5 Tips to Protect Your Medtech Startup’s Innovations.” The article was published in Medical Design & Outsourcing as well as MassDevice.
Continue
Continue Reading 5 Tips to Protect Your Medtech Startup’s Innovations
Greenberg Traurig Tel Aviv and Shanghai Offices Sponsor the First Ever China-Israel Technology, Innovation and Investment Summit
Earlier this month, the first ever China-Israel Technology, Innovation and Investment Summit, jointly sponsored by the Greenberg Traurig Tel Aviv and Shanghai offices, took place in Beijing. The 3-day
Continue Reading Greenberg Traurig Tel Aviv and Shanghai Offices Sponsor the First Ever China-Israel Technology, Innovation and Investment Summit
Greenberg Traurig to Sponsor Two Major Israel Event
Greenberg Traurig will be sponsoring two major Israel events this coming week.
The first is the OurCrowd Global Investor Summit (January 25-26), set to bring together 3,000 investors and companies
Continue Reading Greenberg Traurig to Sponsor Two Major Israel Event